Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study

医学 内科学 化疗 肿瘤科 外科肿瘤学 阶段(地层学) 围手术期 癌症 疾病 人口 胃肠病学 外科 生物 环境卫生 古生物学
作者
Hyung‐Don Kim,Jong Seok Lee,Young Soo Park,Jeong Hwan Yook,Sung Hoon Noh,Youngkyu Park,Young‐Woo Kim,Sang Cheul Oh,Jong Gwang Kim,Min‐Hee Ryu,Jae‐Ho Cheong,Hyunki Kim,Joon Seok Lim,Jae-Hyuk Lee,Suk Hee Heo,Jin Young Kim,Mi Hwa Heo,Young Iee Park,Inho Kim,Yoon‐Koo Kang
出处
期刊:Gastric Cancer [Springer Science+Business Media]
卷期号:25 (6): 1039-1049 被引量:4
标识
DOI:10.1007/s10120-022-01325-6
摘要

In this post hoc analysis of the PRODIGY study, we aimed to investigate factors associated with survival outcomes and provide evidence for designing optimal perioperative treatment strategies for gastric cancer patients receiving neoadjuvant chemotherapy.A total of 212 patients in the neoadjuvant chemotherapy group of the PRODIGY study were included as the study population. The prognostic impact of clinicopathologic factors, including the initial radiological clinical stage (cStage) and post-neoadjuvant chemotherapy pathological stage (ypStage), was analyzed.The median age was 58 years. The majority of patients (77.4%) had cStage III disease, and about 10% and 25% had ypStage 0 and I disease, respectively. According to the initial cStage, progression-free survival (PFS) and overall survival (OS) were significantly different (P < 0.01). PFS and OS were also different according to the ypStage (P < 0.01). In multivariate analyses, cStage IIIC disease (vs. cStage II) and ypStage II and III disease (vs. ypStage 0/I) were independent factors for poor survival outcomes. Based on the patterns of PFS and OS according to both cStage and ypStage, three patient groups were defined. These groups showed distinct PFS and OS (P < 0.01) with 5-year PFS rates of 95.7%, 77.9%, and 31.3% and 5-year OS rates of 95.7%, 82.4%, and 42.5%, respectively.Both initial cStage and ypStage were independent factors for survival outcomes of gastric cancer patients treated with neoadjuvant chemotherapy. Efforts should be made to develop optimal peri-operative treatment strategies for patients at different risks according to cStage and ypStage.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丽丽完成签到,获得积分10
1秒前
3秒前
坐宝马吃地瓜完成签到 ,获得积分10
20秒前
22秒前
烟花应助拾陆采纳,获得10
33秒前
伶俐绿柏完成签到 ,获得积分10
38秒前
研友_VZG7GZ应助Ilyas0525采纳,获得10
43秒前
45秒前
禾页完成签到 ,获得积分10
45秒前
CorisKen应助端庄的萝采纳,获得20
49秒前
打打应助Ilyas0525采纳,获得10
59秒前
晁子枫完成签到 ,获得积分10
1分钟前
张希伦完成签到 ,获得积分10
1分钟前
Emma发布了新的文献求助80
1分钟前
1分钟前
科目三应助Ilyas0525采纳,获得10
1分钟前
DeepLearning发布了新的文献求助10
1分钟前
Jasmineyfz完成签到 ,获得积分10
1分钟前
1分钟前
Ilyas0525完成签到,获得积分10
1分钟前
Emma完成签到,获得积分10
1分钟前
小木林完成签到 ,获得积分10
1分钟前
朴素羊完成签到 ,获得积分10
1分钟前
辛勤的喉完成签到 ,获得积分10
1分钟前
yunt完成签到 ,获得积分10
1分钟前
林利芳完成签到 ,获得积分0
1分钟前
神勇的翠丝完成签到,获得积分10
1分钟前
xiangwang完成签到 ,获得积分10
1分钟前
Joan_89完成签到,获得积分10
2分钟前
juliar完成签到 ,获得积分10
2分钟前
Akim应助DeepLearning采纳,获得10
2分钟前
迈克老狼完成签到 ,获得积分10
2分钟前
Kelevator完成签到,获得积分10
2分钟前
DeepLearning完成签到,获得积分20
2分钟前
2分钟前
DeepLearning发布了新的文献求助10
2分钟前
SOL完成签到 ,获得积分10
2分钟前
丝丢皮的完成签到 ,获得积分10
2分钟前
t铁核桃1985完成签到 ,获得积分10
2分钟前
丝丢皮得完成签到 ,获得积分10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990836
求助须知:如何正确求助?哪些是违规求助? 3532241
关于积分的说明 11256631
捐赠科研通 3271100
什么是DOI,文献DOI怎么找? 1805313
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809236